Recently added articles from Worldwide Biotech:
QRXPHARMA/LIAONING NUOKANG MEDICINES TO DEVELOP VENOMICS.
Nov 01, 2009; ... QRxPharma(OTCQX:QRXPY), has announced a strategic alliance with Liaoning Nuokang Medicines Co. Ltd. (Nuokang), a Chinese biopharmaceutical company based in Shenyang, China, to develop and commercialise QRxPharma's venomics assets for the Chinese market. The strategic alliance involves ...
METHYLGENE TO RESUME DEVELOPMENT OF MGCD0103 (MOCETINOSTAT).
Nov 01, 2009; ... MethylGene Inc. (TSX:MYG), Montreal, Quebec. has announced that the U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold placed on MGCD0103, the company's proprietary selective histone deacetylase (HDAC) inhibitor for cancer. New patient enrollment in the refractory ...
STEMCELLS, INC. TO ADVANCE CELL-BASED TECHNOLOGIES.
Nov 01, 2009; ... StemCells, Inc. (NASDAQ: STEM). Palo Alto, Calif., has announced organizational initiatives focused on growing its specialty SC ProvenR cell culture product business and advancing the development and commercialization of its central nervous system (CNS) cell-based assay platforms for use ...
